This site is intended for healthcare professionals only
LoginRegister
Fire at Emcure Pharmas Pune Plant, Operations Temporarily HaltedFire at Emcure Pharma's Pune Plant, Operations Temporarily Halted
Govt Proposes Scrapping Mandatory HIV, Hepatitis Tests for Certain Blood ProductsMedicine Security Is National Security: IPA Welcomes India-US Interim Trade Deal
Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11%Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up...
After Auditing 90% of Cough Syrup Units, CDSCO Tightens GMP Net, 850 CAPA Notices ServedPharma Firms May Need Prior Approval for Major Drug Changes Under NDCT Draft Amendment
Aurobindo Pharma Gets 11 USFDA Observations at Eugia UnitAurobindo Pharma Gets 11 USFDA Observations at Eugia Unit
Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in USLupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million Market
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine Patch
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusGST Department Launches Search, Inspection at Cipla's Maharashtra Facilities
Shukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics, Cancer Therapy TechShukra Pharma to Invest Rs 600 Cr in Greater Noida Medical Device Park, Enters Surgical Robotics,...
From Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing ReformsFrom Allergy Pills to PPIs: MPs Flag Massive Overpricing of Medicines, Seek Pricing Reforms
Alembic Pharmas Karakhadi Injectable Facility USFDA InspectionAlembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic
Zydus Settles Mirabegron Patent Dispute With Astellas for USD 120 MillionUSFDA Grants Orphan Drug Status to Zydus' Desidustat for Sickle Cell Disease
X